Full-Time

Quality Engineer

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Develops and sells medical devices and diagnostics

Compensation Overview

$64.7k - $106.7kAnnually

Mid, Senior

El Paso, TX, USA

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor’s degree or foreign equivalent degree in Engineering (any) or a related field
  • Four (4) years of related work experience with a Bachelor’s degree, or two (2) years of related work experience with a Master’s degree
  • Experience with Quality Engineering tools, such as sampling plans, root cause analysis, or statistics
  • Statistical and risk assessment techniques
  • Performing qualitative risk analysis
  • Test method development and validation
  • Analyzing and optimizing manufacturing and quality systems
  • Creating, reviewing, and coordinating test protocols and reports
  • Knowledge of regulatory requirements, including ISO 13485, ISO 14971
Responsibilities
  • Develop, change, and supervise Quality inspections
  • Ensure quality control for the customer and the plant during the manufacturing process
  • Process monitoring and adjustment, and product improvement
  • Document activities along the review and maintenance of operating procedures
  • Develop, implement, and improve Quality procedures
  • Coordinate effort with other Departments to establish controls and process capabilities
  • Support process validation, acceptance, internal and external audits and resulting corrective actions
  • Supervise the performance of assigned product lines regarding product quality, scrap, rejection rates and other applicable metrics
  • Assume a leadership role in analyzing and resolving process/product issues
  • Develop or improve test methods for inspection
  • Monitor customer complaints and trends, respond with specific corrective actions

BD (Becton, Dickinson and Company) focuses on improving health through medical technology. The company operates in three main areas: BD Medical, BD Life Sciences, and BD Interventional, each targeting different healthcare needs. BD develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to hospitals, laboratories, and healthcare providers worldwide. Their products aim to enhance patient outcomes, reduce healthcare costs, and improve safety and efficiency in medical care. What sets BD apart from competitors is its comprehensive approach to healthcare solutions across various segments, allowing for a wide range of services and products. The company's goal is to advance healthcare by providing effective tools and technologies that support better medical discovery and care delivery.

Company Size

10,001+

Company Stage

IPO

Headquarters

Eysins, Switzerland

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • $1.2B investment boosts syringe manufacturing and drug delivery systems.
  • Acquisition of Cubex LLC's assets strengthens BD's cloud-based healthcare solutions.
  • Federal funding supports expansion of COVID-19 test production capabilities.

What critics are saying

  • Increased competition in the pre-fillable syringe market.
  • Potential integration challenges with Cubex LLC's Medical Business assets.
  • Leadership changes may disrupt ongoing projects.

What makes Becton Dickinson unique

  • BD's global reach spans North America, EMEA, Greater Asia, and Latin America.
  • The company excels in medical devices, laboratory equipment, and diagnostic products.
  • BD's commitment to innovation enhances patient outcomes and operational efficiencies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...